C9ORF72 Gene GGGGCC Hexanucleotide Expansion: A High Clinical Variability from Amyotrophic Lateral Sclerosis to Frontotemporal Dementia

被引:1
|
作者
Kortazar-Zubizarreta, Izaro [1 ]
Manero-Azua, Africa [2 ]
Afonso-Aguera, Juan [3 ]
Perez de Nanclares, Guiomar [2 ]
机构
[1] Araba Univ Hosp Txagorritxu, Bioaraba Hlth Res Inst, Dept Neurol, Vitoria 01009, Spain
[2] Araba Univ Hosp, Bioaraba Hlth Res Inst, Mol Epi Genet Lab, Vitoria 01009, Spain
[3] Hosp Univ Cent Asturias, Dept Neurol, Oviedo 33006, Spain
来源
JOURNAL OF PERSONALIZED MEDICINE | 2023年 / 13卷 / 09期
关键词
C9ORF72; gene; frontotemporal dementia; amyotrophic lateral sclerosis; ALS-FTD; REPEAT EXPANSION; LOBAR DEGENERATION; RNA FOCI; ANTISENSE TRANSCRIPTS; MUTATIONS; ALS; NEUROPATHOLOGY; TOXICITY; FEATURES; TRANSLATION;
D O I
10.3390/jpm13091396
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
The expanded GGGGCC hexanucleotide repeat (HRE) in the non-coding region of the C9ORF72 gene (C9ORF72-HRE) is the most common genetic cause of familial forms of amyotrophic lateral sclerosis (ALS), FTD, and concurrent ALS and FTD (ALS-FTD), in addition to contributing to the sporadic forms of these diseases. Both syndromes overlap not only genetically, but also sharing similar clinical and neuropathological findings, being considered as a spectrum. In this paper we describe the clinical-genetic findings in a Basque family with different manifestations within the spectrum, our difficulties in reaching the diagnosis, and a narrative review, carried out as a consequence, of the main features associated with C9ORF72-HRE. Family members underwent a detailed clinical assessment, neurological examination, and genetic analysis by repeat-primed PCR. We studied 10 relatives of a symptomatic carrier of the C9ORF72-HRE expansion. Two of them presented the expansion in the pathological range, one of them was symptomatic whereas the other one remained asymptomatic at 72 years. Given the great intrafamilial clinical variability of C9ORF72-HRE, the characterization of patients and family members with particular clinical and genetic subgroups within ALS and FTD becomes a bottleneck for medication development, in particular for genetically focused medicines for ALS and FTD.
引用
收藏
页数:16
相关论文
共 50 条
  • [21] C9orf72 expansions in frontotemporal dementia and amyotrophic lateral sclerosis
    Rohrer, Jonathan D.
    Isaacs, Adrian M.
    Mizlienska, Sarah
    Mead, Simon
    Lashley, Tammaryn
    Wray, Selina
    Sidle, Katie
    Fratta, Pietro
    Orrell, Richard W.
    Hardy, John
    Holton, Janice
    Revesz, Tamas
    Rossor, Martin N.
    Warren, Jason D.
    LANCET NEUROLOGY, 2015, 14 (03): : 291 - 301
  • [22] Amyotrophic lateral sclerosis/frontotemporal dementia with predominant manifestations of obsessive-compulsive disorder associated to GGGGCC expansion of the c9orf72 gene
    Calvo, Andrea
    Moglia, Cristina
    Canosa, Antonio
    Cistaro, Angelina
    Valentini, Consuelo
    Carrara, Giovanna
    Soldano, Enzo
    Ilardi, Antonio
    Bersano, Enrica
    Bertuzzo, Davide
    Brunetti, Maura
    Ossola, Irene
    Restagno, Gabriella
    Chio, Adriano
    JOURNAL OF NEUROLOGY, 2012, 259 (12) : 2723 - 2725
  • [23] Role of the C9ORF72 Gene in the Pathogenesis of Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
    Zongbing Hao
    Rui Wang
    Haigang Ren
    Guanghui Wang
    Neuroscience Bulletin, 2020, 36 : 1057 - 1070
  • [24] Role of the C9ORF72 Gene in the Pathogenesis of Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
    Hao, Zongbing
    Wang, Rui
    Ren, Haigang
    Wang, Guanghui
    NEUROSCIENCE BULLETIN, 2020, 36 (09) : 1057 - 1070
  • [25] Role of the C9ORF72 Gene in the Pathogenesis of Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
    Zongbing Hao
    Rui Wang
    Haigang Ren
    Guanghui Wang
    NeuroscienceBulletin, 2020, 36 (09) : 1057 - 1070
  • [26] C9ORF72 Hexanucleotide Repeat Expansion in a Cohort of Italian Patients Affected by Amyotrophic Lateral Sclerosis with and without Frontotemporal Dementia
    Del Bo, Roberto
    Corti, Stefania
    Riboldi, Giulietta
    Ranieri, Michela
    Fenoglio, Chiara
    Galimberti, Daniela
    Scarpini, Elio
    Bresolin, Nereo
    Comi, Giacomo
    NEUROLOGY, 2012, 78
  • [27] Clinical Update on C9orf72: Frontotemporal Dementia, Amyotrophic Lateral Sclerosis, and Beyond
    Saracino, Dario
    Le Ber, Isabelle
    FRONTOTEMPORAL DEMENTIAS: EMERGING MILESTONES OF THE 21ST CENTURY, 2021, 1281 : 67 - 76
  • [28] Diversity of Clinical Phenotypes in Frontotemporal Dementia with C9orf72 Hexanucleotide Expansion
    Gomez-Tortosa, Estrella
    Gallego, Jesus
    Guerrero, Rosa
    Sainz, Ma Jose
    Gil-Neciga, Eulogio
    Franco, Emilio
    Trujillo, Ma Jose
    Ayuso, Carmen
    Diaz, Asuncion
    Perez-Perez, Julian
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2012, 33 : 216 - 216
  • [29] Homozygosity for the C9orf72 GGGGCC repeat expansion in frontotemporal dementia
    Fratta, Pietro
    Poulter, Mark
    Lashley, Tammaryn
    Rohrer, Jonathan D.
    Polke, James M.
    Beck, Jon
    Ryan, Natalie
    Hensman, Davina
    Mizielinska, Sarah
    Waite, Adrian J.
    Lai, Mang-Ching
    Gendron, Tania F.
    Petrucelli, Leonard
    Fisher, Elizabeth M. C.
    Revesz, Tamas
    Warren, Jason D.
    Collinge, John
    Isaacs, Adrian M.
    Mead, Simon
    ACTA NEUROPATHOLOGICA, 2013, 126 (03) : 401 - 409
  • [30] Characterization of the repeat expansion size in C9orf72 in amyotrophic lateral sclerosis and frontotemporal dementia
    Dols-Icardo, Oriol
    Garcia-Redondo, Alberto
    Rojas-Garcia, Ricard
    Sanchez-Valle, Raquel
    Noguera, Aina
    Gomez-Tortosa, Estrella
    Pastor, Pau
    Hernandez, Isabel
    Esteban-Perez, Jesus
    Suarez-Calvet, Marc
    Anton-Aguirre, Sofia
    Amer, Guillermo
    Ortega-Cubero, Sara
    Blesa, Rafael
    Fortea, Juan
    Alcolea, Daniel
    Capdevila, Aura
    Antonell, Anna
    Llado, Albert
    Luis Munoz-Blanco, Jose
    Mora, Jesus S.
    Galan-Davila, Lucia
    Javier Rodriguez De Rivera, Francisco
    Lleo, Alberto
    Clarimon, Jordi
    HUMAN MOLECULAR GENETICS, 2014, 23 (03) : 749 - 754